NCT06499285 2026-03-11
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Takeda
Phase 3 Recruiting
Clinical Trials
10 trialsNCT05320198 2026-03-09
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Disc Medicine, Inc
Phase 1/2 Recruiting
NCT07328191 2026-02-12
Q-TRANS
Centre Hospitalier Universitaire de Nice
Phase NA Recruiting
NCT05732961 2025-12-10
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
NCT07025512 2025-11-14
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05407987 2025-04-25
FORGE II
AHS Cancer Control Alberta
Phase 3 Recruiting
NCT06245746 2025-03-21
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting
NCT06737081 2024-12-17
SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2 Recruiting
NCT06018896 2024-06-06
PTCA199-4
Fudan University
Phase 2 Recruiting
NCT05913414 2023-06-22
Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Recruiting